Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bngo · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bionano Genomics, Inc. (BNGO) measures how much investors pay for each dollar of the company's trailing earnings. BNGO's current PE ratio of N/A is calculated by dividing its stock price of $1.17 by its TTM earnings per share of -$5.80.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bionano Genomics, Inc.You BNGO | $4M | N/A | — | -$5.80 |
 AIM ImmunoTech Inc. AIM | $2M | N/A | — | -$8.62 |
 BNB Plus Corp. BNBX | $1M | N/A | — | -$29.29 |
 GBS Inc. GBS | $0M | N/A | — | -$2.00 |
 Pasithea Therapeutics Corp. KTTA | $4M | N/A | — | -$2.91 |
 Mainz Biomed B.V. MYNZ | $15M | N/A | — | -$2.70 |
 ENDRA Life Sciences Inc. NDRA | $3M | N/A | — | -$8.93 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.85 | — | |
2024-12-31 FY2024 | — | $-58.87 | — | |
2023-12-31 FY2023 | — | $-400.59 | — | |
2022-12-31 FY2022 | — | $-269.69 | — | |
2021-12-31 FY2021 | — | $-153.94 | — | |
2020-12-31 FY2020 | — | $-231.94 | — | |
2019-12-31 FY2019 | — | $-70257.09 | — | |
2018-12-31 FY2018 | — | $-92244.43 | — | |
2017-12-31 FY2017 | — | $0.00 | — | |
2016-12-31 FY2016 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bionano Genomics, Inc. (BNGO) measures how much investors pay for each dollar of the company's trailing earnings. BNGO's current PE ratio of N/A is calculated by dividing its stock price of $1.17 by its TTM earnings per share of -$5.80.
Frequently asked questions
BNGO pe ratio · 6 questionsBNGO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.17 and TTM EPS of -$5.80. Data sourced from Financial Modeling Prep via BNGO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bionano Genomics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08